BCL2 and Miyoshi myopathy: Although clinical data availability limitations resulted in a smaller sample size, we found no significant difference between the miRNAs (Figure S5A) or BCL2 (Figure S5B, left graph) expression levels and the presence of t(11:14), albeit a trend for lower miRNA expression was noted among AL amyloidosis patients in comparison with MM patients.